Natera Announces Enrollment Completion for RenaCARE Study
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced full enrollment for the RenaCARE (Renasight Clinical...
Source: prnewswire.com
Renasight Clinical Application News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Renasight Clinical Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Renasight Clinical Application Today - Breaking & Trending Today
Natera Announces Definitive Study to Evaluate the Clinical Utility of Renasight in the Diagnosis and Management of Chronic Kidney Disease (CKD)
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the RenaCARE (Renasight Clinical Application, Review and...
Source: prnewswire.com
Natera Announces Definitive Study to Evaluate the Clinical Utility of Renasight in the Diagnosis and Management of Chronic Kidney Disease (CKD)
/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the RenaCARE (Renasight Clinical Application, Review and...
Source: prnewswire.com